History of Esbriet (pirfenidone)

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

PF_history esbriet

While the therapy was approved for use in 2014 in the US, Japan was the first country to approve its commercial use in 2008, followed by India in 2010, Europe in 2011, and China in 2013. Because IPF is considered a rare condition, this drug was designated as an ‘orphan drug’ in 2004.

Learn more: http://bit.ly/Esbriet

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums